Dr Emily Harrold

Dr Emily Harrold is currently a medical oncology consultant at the Mater Misericordiae University Hospital in Dublin having recently completed an advanced oncology fellowship in Memorial Sloan Kettering Cancer Centre in New York where her research focused on genetic predisposition syndromes and the impact of novel therapeutics on mitigating cancer risk. She is a University College Dublin Medical School graduate who completed her specialist Medical Oncology training in Ireland through the Royal College of Physicians of Ireland.

Her career to date has been distinguished by both Irish and international awards including ISMO Bursary awards, the Paddy Johnston Colorectal Cancer Research Award and most recently ASCO Special Merit Awards at the annual ASCO meetings in 2022 and in 2023 for her research evaluating the risk of neoplasia in patients with Lynch syndrome post immunotherapy treatment and somatic-germline integration to evaluate the contribution of non-classical germline pathogenic variants to colorectal carcinogenesis. She was also awarded a Conquer Cancer ASCO Young investigator Grant in April 2023 to further expand her study, in collaboration with the BROAD institute, in patients with Lynch syndrome treated with immunotherapy.

Her research interests include cancer immunology, mechanisms of resistance to immunotherapy, inherited cancer genetics and early onset cancers both in cohorts defined by pathogenic germline variants and those without.